Suppr超能文献

急性缺血性脑卒中患者血管内治疗后无效再通的发生及预测因素:一项多中心研究。

Occurrence and predictors of futile recanalization following endovascular treatment among patients with acute ischemic stroke: a multicenter study.

机构信息

Zeenat Qureshi Stroke Research Center, University of Minnesota, Minneapolis, Minnesota, USA.

出版信息

AJNR Am J Neuroradiol. 2010 Mar;31(3):454-8. doi: 10.3174/ajnr.A2006. Epub 2010 Jan 14.

Abstract

BACKGROUND AND PURPOSE

Although recanalization is the goal of thrombolysis, it is well recognized that it fails to improve outcome of acute stroke in a subset of patients. Our aim was to assess the rate of and factors associated with "futile recanalization," defined by absence of clinical benefit from recanalization, following endovascular treatment of acute ischemic stroke.

MATERIALS AND METHODS

Data from 6 studies of acute ischemic stroke treated with mechanical and/or pharmacologic endovascular treatment were analyzed. "Futile recanalization" was defined by the occurrence of unfavorable outcome (mRS score of > or = 3 at 1-3 months) despite complete angiographic recanalization (Qureshi grade 0 or TIMI grade 3).

RESULTS

Complete recanalization was observed in 96 of 270 patients treated with IA thrombolysis. Futile recanalization was observed in 47 (49%). In univariate analysis, patients with futile recanalization were older (73 +/- 11 versus 58 +/- 15 years, P < .0001) and had higher median initial NIHSS scores (19 versus 14, P < .0001), more frequent BA occlusion (17% versus 4%, P = .049), less frequent MCA occlusion (53% versus 76%, P = .032), and a nonsignificantly higher rate of symptomatic hemorrhagic complications (2% versus 9%, P = .2). In logistic regression analysis, futile recanalization was positively associated with age > 70 years (OR, 4.4; 95% CI, 1.9-10.5; P = .0008) and initial NIHSS score 10-19 (OR, 3.8; 95% CI, 1.7-8.4; P = .001), and initial NIHSS score > or = 20 (OR, 64.4; 95% CI, 28.8-144; P < .0001).

CONCLUSIONS

Futile recanalization is a relatively common occurrence following endovascular treatment, particularly among elderly patients and those with severe neurologic deficits.

摘要

背景与目的

尽管再通是溶栓的目标,但众所周知,在一部分患者中,它无法改善急性脑卒中的预后。我们的目的是评估血管内治疗急性缺血性脑卒中后,无临床获益的“无效再通”(再通后出现不良结局,即 mRS 评分在 1-3 个月时为>或=3 分)的发生率和相关因素。

材料和方法

分析了 6 项接受机械和/或药物血管内治疗的急性缺血性脑卒中研究的数据。“无效再通”定义为尽管完全血管再通(Qureshi 分级 0 级或 TIMI 分级 3 级),但仍出现不良结局(mRS 评分在 1-3 个月时为>或=3 分)。

结果

IA 溶栓治疗的 270 例患者中,96 例完全再通。96 例患者中有 47 例(49%)出现无效再通。单因素分析显示,无效再通组患者年龄更大(73±11 岁比 58±15 岁,P<.0001),初始 NIHSS 评分中位数更高(19 分比 14 分,P<.0001),基底动脉闭塞更常见(17%比 4%,P=.049),大脑中动脉闭塞较少见(53%比 76%,P=.032),症状性出血性并发症发生率虽无统计学差异,但更高(2%比 9%,P=.2)。Logistic 回归分析显示,年龄>70 岁(OR,4.4;95%CI,1.9-10.5;P=.0008)和初始 NIHSS 评分 10-19 分(OR,3.8;95%CI,1.7-8.4;P=.001)与无效再通呈正相关,而初始 NIHSS 评分>或=20 分(OR,64.4;95%CI,28.8-144;P<.0001)与无效再通呈正相关。

结论

血管内治疗后无效再通较为常见,尤其是在老年患者和神经功能缺损严重的患者中。

相似文献

引用本文的文献

本文引用的文献

7
Methodology of the Interventional Management of Stroke III Trial.卒中III期试验的介入管理方法
Int J Stroke. 2008 May;3(2):130-7. doi: 10.1111/j.1747-4949.2008.00151.x.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验